Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015622018> ?p ?o ?g. }
- W2015622018 endingPage "490" @default.
- W2015622018 startingPage "477" @default.
- W2015622018 abstract "Fusion proteins containing immunoglobulin Fc domains attached to bioactive moieties have been developed as therapeutic agents against several diseases. Here, we describe the development and characteristics of a novel fusion protein (FLSC R/T–IgG1) that targets CCR5, the major coreceptor for HIV-1 during primary infection. FLSC R/T–IgG1 was expressed from a synthetic gene that linked a single chain gp120–CD4 complex containing an R5 gp120 sequence with the hinge–CH2–CH3 portion of human immunoglobulin γ subtype 1. Purified FLSC R/T–IgG1 exhibited a molecular mass of 189 kDa under reducing conditions, which matched the expected size of one polypeptide chain. Chemically crosslinked or untreated FLSC R/T–IgG1 exhibited a mass of a 360-kDa polypeptide under reducing and nonreducing conditions, which indicated that the molecule adopts a disulfide-linked bivalent structure. The chimeric molecule bound specifically to CCR5-expressing cells and to peptides derived from the CCR5 N-terminus. Such binding was more efficient than what was obtained with a monomeric single chain gp120–CD4 complex. FLSC R/T–IgG1 binding to CCR5 was blocked by preincubation of coreceptor-expressing cells with CCR5 ligands and by antibody to the coreceptor binding domain of gp120. Conversely, FLSC R/T–IgG1 blocked the binding of chemokine to CCR5. However, FLSC R/T–IgG1 did not trigger intracellular Ca2+ mobilization in peripheral blood mononuclear cells. FLSC R/T–IgG1 potently neutralized primary R5 HIV-1 in both a PBMC-based assay and cell line-based assays but did not affect the replication of X4 viruses. These findings suggest that FLSC R/T–IgG1 might be used as a possible therapeutic agent against HIV." @default.
- W2015622018 created "2016-06-24" @default.
- W2015622018 creator A5030545878 @default.
- W2015622018 creator A5031256695 @default.
- W2015622018 creator A5033051900 @default.
- W2015622018 creator A5037187532 @default.
- W2015622018 creator A5043353900 @default.
- W2015622018 creator A5048234512 @default.
- W2015622018 creator A5055924737 @default.
- W2015622018 creator A5061216308 @default.
- W2015622018 date "2006-06-01" @default.
- W2015622018 modified "2023-10-08" @default.
- W2015622018 title "An Immunoglobulin Fusion Protein Based on the gp120-CD4 Receptor Complex Potently Inhibits Human Immunodeficiency Virus Type 1<i>in Vitro</i>" @default.
- W2015622018 cites W1510768077 @default.
- W2015622018 cites W1512026049 @default.
- W2015622018 cites W1539312716 @default.
- W2015622018 cites W1598711637 @default.
- W2015622018 cites W1679721892 @default.
- W2015622018 cites W1782049572 @default.
- W2015622018 cites W1817018401 @default.
- W2015622018 cites W1923928177 @default.
- W2015622018 cites W1966515400 @default.
- W2015622018 cites W1966815718 @default.
- W2015622018 cites W1968594568 @default.
- W2015622018 cites W1971777539 @default.
- W2015622018 cites W1975932650 @default.
- W2015622018 cites W1981164507 @default.
- W2015622018 cites W1981440980 @default.
- W2015622018 cites W1981644527 @default.
- W2015622018 cites W1982944348 @default.
- W2015622018 cites W1984811742 @default.
- W2015622018 cites W1986574361 @default.
- W2015622018 cites W1989035987 @default.
- W2015622018 cites W1993634191 @default.
- W2015622018 cites W1995303508 @default.
- W2015622018 cites W1995420391 @default.
- W2015622018 cites W1996183144 @default.
- W2015622018 cites W2002164494 @default.
- W2015622018 cites W2006734012 @default.
- W2015622018 cites W2008130406 @default.
- W2015622018 cites W2009324334 @default.
- W2015622018 cites W2010638326 @default.
- W2015622018 cites W2012730930 @default.
- W2015622018 cites W2015404088 @default.
- W2015622018 cites W2017551575 @default.
- W2015622018 cites W2018600081 @default.
- W2015622018 cites W2018964839 @default.
- W2015622018 cites W2022522156 @default.
- W2015622018 cites W2026444780 @default.
- W2015622018 cites W2029288933 @default.
- W2015622018 cites W2036741092 @default.
- W2015622018 cites W2037580692 @default.
- W2015622018 cites W2041557530 @default.
- W2015622018 cites W2042578530 @default.
- W2015622018 cites W2044046899 @default.
- W2015622018 cites W2044052199 @default.
- W2015622018 cites W2044809899 @default.
- W2015622018 cites W2051377225 @default.
- W2015622018 cites W2051785641 @default.
- W2015622018 cites W2055208054 @default.
- W2015622018 cites W2058252938 @default.
- W2015622018 cites W2068659795 @default.
- W2015622018 cites W2074969682 @default.
- W2015622018 cites W2075926278 @default.
- W2015622018 cites W2076760824 @default.
- W2015622018 cites W2077153526 @default.
- W2015622018 cites W2081769332 @default.
- W2015622018 cites W2083612980 @default.
- W2015622018 cites W2083803997 @default.
- W2015622018 cites W2084197987 @default.
- W2015622018 cites W2085577978 @default.
- W2015622018 cites W2086783015 @default.
- W2015622018 cites W2089174726 @default.
- W2015622018 cites W2090763940 @default.
- W2015622018 cites W2091330377 @default.
- W2015622018 cites W2092664889 @default.
- W2015622018 cites W2098781795 @default.
- W2015622018 cites W2107656195 @default.
- W2015622018 cites W2113282092 @default.
- W2015622018 cites W2115906128 @default.
- W2015622018 cites W2117719816 @default.
- W2015622018 cites W2118820599 @default.
- W2015622018 cites W2119745827 @default.
- W2015622018 cites W2122985048 @default.
- W2015622018 cites W2124467421 @default.
- W2015622018 cites W2125231927 @default.
- W2015622018 cites W2126597682 @default.
- W2015622018 cites W2128461524 @default.
- W2015622018 cites W2129875326 @default.
- W2015622018 cites W2130635171 @default.
- W2015622018 cites W2135739941 @default.
- W2015622018 cites W2136056069 @default.
- W2015622018 cites W2138758139 @default.
- W2015622018 cites W2140478082 @default.
- W2015622018 cites W2144644150 @default.
- W2015622018 cites W2145718464 @default.
- W2015622018 cites W2146519771 @default.
- W2015622018 cites W2147169218 @default.